Inflammatory Response and Electrocardiographic Examination in Horses Vaccinated against Equine Herpesvirus (Ehv-1)
- PMID: 35327175
- PMCID: PMC8944655
- DOI: 10.3390/ani12060778
Inflammatory Response and Electrocardiographic Examination in Horses Vaccinated against Equine Herpesvirus (Ehv-1)
Abstract
This study aimed to evaluate possible abnormalities in electrocardiographic findings, and changes in cardiac troponin I (cTnI) and inflammatory biomarkers (serum amyloid A (SAA) and C-reactive protein (CRP)) after inactivated herpesvirus vaccine administration. Eighteen healthy horses were included. All animals were vaccinated with Pneumoequine® (Merial, France) according to the protocol provided by the manufacturer. They were evaluated 1 day before the first dose of vaccination (D0), and 7 days (D1) and 14 days (D2) afterwards. At D0, D1, and D2, a blood sample was taken for the evaluation of SAA, cTnI, and CRP. An electrocardiographic examination was also performed. The data obtained suggested the possible involvement of the myocardium following vaccination against herpesvirus 1, mostly related to an inflammatory response.
Keywords: C-reactive protein; arrhythmias; cardiac troponin I; equine herpesvirus; serum amyloid A.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Concurrent vaccination against equine influenza and equine herpesvirus - a practical approach.Influenza Other Respir Viruses. 2016 Sep;10(5):433-7. doi: 10.1111/irv.12396. Epub 2016 Jul 2. Influenza Other Respir Viruses. 2016. PMID: 27169603 Free PMC article.
-
Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges.Vet Microbiol. 2003 Mar 20;92(1-2):1-17. doi: 10.1016/s0378-1135(02)00358-9. Vet Microbiol. 2003. PMID: 12488066
-
Duration of immunity induced by an adjuvanted and inactivated equine influenza, tetanus and equine herpesvirus 1 and 4 combination vaccine.Vet Q. 2001 Nov;23(4):210-7. doi: 10.1080/01652176.2001.9695116. Vet Q. 2001. PMID: 11765243 Clinical Trial.
-
Equine Herpesvirus-I Infection in Horses: Recent Updates on its Pathogenicity, Vaccination, and Preventive Management Strategies.J Equine Vet Sci. 2020 Apr;87:102923. doi: 10.1016/j.jevs.2020.102923. Epub 2020 Jan 11. J Equine Vet Sci. 2020. PMID: 32172913 Review.
-
Equine herpesviruses 1 (EHV-1) and 4 (EHV-4)--epidemiology, disease and immunoprophylaxis: a brief review.Vet J. 2005 Jul;170(1):14-23. doi: 10.1016/j.tvjl.2004.04.018. Vet J. 2005. PMID: 15993786 Review.
Cited by
-
Immune Response after Vaccination against Tick-Borne Encephalitis Virus (TBEV) in Horses.Vaccines (Basel). 2024 Sep 19;12(9):1074. doi: 10.3390/vaccines12091074. Vaccines (Basel). 2024. PMID: 39340104 Free PMC article.
-
Plasma Cardiac Troponin-I Concentration in Normal Horses and in Horses with Cardiac Abnormalities.Animals (Basel). 2025 Jan 3;15(1):92. doi: 10.3390/ani15010092. Animals (Basel). 2025. PMID: 39795035 Free PMC article.
References
-
- Allen G.P., Kydd J.H., Slater J.D., Smith K.C. Equid herpesvirus 1 and equid herpesvirus 4 infections. Infect. Dis. Livest. 2004;2:829–859.
-
- Vandekerckhove A.P., Glorieux S., Gryspeerdt A.C., Steukers L., Van Doorsselaere J., Osterrieder N., Van de Walle G.R., Nauwynck H.J. Equine alphaherpesviruses (EHV-1 and EHV-4) differ in their efficiency to infect mononuclear cells during early steps of infection in nasal mucosal explants. Vet. Microbiol. 2011;152:21–28. doi: 10.1016/j.vetmic.2011.03.038. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous